Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:appointed_by |
gptkb:tablet
|
| gptkbp:approves |
hormone replacement therapy
|
| gptkbp:brand |
gptkb:Aviane
gptkb:Estrostep gptkb:Femcon_Fe gptkb:Jolessa gptkb:Kariva gptkb:Lo_Loestrin_Fe gptkb:Lybrel gptkb:Microgestin gptkb:Ocella gptkb:Seasonale gptkb:Slynd gptkb:Tri_Nessa gptkb:Loestrin gptkb:Nuva_Ring gptkb:Alesse gptkb:Ortho_Tri-Cyclen gptkb:Nikki gptkb:Yasmin gptkb:Cryselle Yaz Beyaz Phexxi Brevicon Natazia Sronyx Syeda Zafemy Zovia |
| gptkbp:developed_by |
pharmaceutical companies
|
| gptkbp:first_introduced |
1950s
|
| https://www.w3.org/2000/01/rdf-schema#label |
ethinylestradiol
|
| gptkbp:ingredients |
C20 H24 O2
|
| gptkbp:interacts_with |
smoking
|
| gptkbp:lifespan |
13-27 hours
|
| gptkbp:mass |
296.4 g/mol
|
| gptkbp:metabolism |
liver
|
| gptkbp:side_effect |
headache
nausea breast tenderness |
| gptkbp:type_of |
57-63-6
|
| gptkbp:used_in |
oral contraceptives
|
| gptkbp:bfsParent |
gptkb:norgestimate
|
| gptkbp:bfsLayer |
5
|